---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-25-044913"
form_type: "8-K"
ticker: "SILO"
cik: "0001514183"
company_name: "Silo Pharma, Inc."
filed_at: "2025-05-16T23:59:59+00:00"
generated_at: "2026-05-21T03:10:01.945954+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Silo Pharma closes $2M public offering of common stock and warrants

## Summary
- Offered 3,333,338 shares (or pre-funded warrants) plus Series A-1 and A-2 warrants for up to 3,333,338 shares each.
- Combined price $0.60/unit; gross proceeds ~$2M, net ~$1.56M after fees and expenses.
- Series A-1 warrants exercise price $0.60, expire 5 years; Series A-2 warrants $0.60, expire 18 months from issuance.
- H.C. Wainwright exclusive placement agent; received 7.5% cash fee, 1% management fee, and 250,000 warrants at $0.75.
- Net proceeds to be used for working capital and general corporate purposes.

## SEC filing metadata
- accession: 0001213900-25-044913
- form_type: 8-K
- ticker: SILO
- cik: 0001514183
- company_name: Silo Pharma, Inc.
- filed_at: 2025-05-16T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1514183/000121390025044913/0001213900-25-044913-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1514183/000121390025044913/ea0242442-8k_silo.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-25-044913
- JSON: https://secwatch.observer/filing/0001213900-25-044913.json
- Plain text: https://secwatch.observer/filing/0001213900-25-044913.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.